Skip to main content
. 2021 Nov 21;13(22):5835. doi: 10.3390/cancers13225835

Figure 3.

Figure 3

(A,B) Overall survival of refractory and total (refractory after surgery + non-resectable TNBC d/t progression) groups (p < 0.001). (C,D) Progression-free survival of refractory and total (refractory after surgery + non-resectable TNBC d/t progression) groups (p < 0.001). Abbreviation: mTNBC, metastatic triple-negative breast cancer.